Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019 [1]   39,659    
Balance at Dec. 31, 2019 $ 3,223,308 $ 3,966 $ 3,198,076 $ 21,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 216,565     216,565
Restricted stock (in shares) [1]   14    
Restricted stock 3,142 $ 1 3,141  
Other (112)   (112)  
Balance (in shares) at Mar. 31, 2020 [1]   39,673    
Balance at Mar. 31, 2020 3,442,903 $ 3,967 3,201,105 237,831
Balance (in shares) at Dec. 31, 2020   39,759    
Balance at Dec. 31, 2020 711,002 $ 398 3,222,959 (2,512,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (80,407)     (80,407)
Restricted stock (in shares)   13    
Restricted stock 2,609   2,609  
Warrant exercises (in shares)   6,385    
Warrant exercises 134,818 $ 64 134,754  
Balance (in shares) at Mar. 31, 2021   46,157    
Balance at Mar. 31, 2021 $ 768,022 $ 462 $ 3,360,322 $ (2,592,762)
[1] All share amounts have been retroactively adjusted for the Company’s 1-for-10 reverse stock split effective August 7, 2020. See “Note 10 - Stockholders’ Equity” for additional information.